journal cover

Computational drug repurposing for inflammatory bowel disease using genetic information

Computational and Structural Biotechnology Journal

Feb 8, 2019

Liam Grenier, Pingzhao Hu

Abstract

As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually improved, there has been a demand for methods that can use this data in a clinically significant way. Genome-wide association analyses for IBD have identified 232 risk genetic loci for the disorder. Whi...read more

Mentioned in this Paper

Genome-Wide Association Study
Genes
Candidate Disease Gene
Adverse Effects
Pharmacologic Substance
Pharmacotherapy
Inflammatory Bowel Diseases
Analysis
Computational Technique
Gene Mutant
1
Paper Details
References
  • References
  • Citations1
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.

Similar Papers Found In These Feeds

Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

Human Heredity

Prioritized subset analysis: improving power in genome-wide association studies

Human HeredityOctober 16, 2007
Chun LiRichard M Watanabe
Inflammatory Bowel Diseases

Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information

Inflammatory Bowel DiseasesOctober 19, 2016
Valerie CollijRinse K Weersma
© 2020 Meta ULC. All rights reserved

Computational drug repurposing for inflammatory bowel disease using genetic information

Computational and Structural Biotechnology Journal

Feb 8, 2019

Liam Grenier, Pingzhao Hu

PMID: 30728920

DOI: 10.1016/j.csbj.2019.01.001

Abstract

As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually improved, there has been a demand for methods that can use this data in a clinically significant way. Genome-wide association analyses for IBD have identified 232 risk genetic loci for the disorder. Whi...read more

Mentioned in this Paper

Genome-Wide Association Study
Genes
Candidate Disease Gene
Adverse Effects
Pharmacologic Substance
Pharmacotherapy
Inflammatory Bowel Diseases
Analysis
Computational Technique
Gene Mutant
1

Similar Papers Found In These Feeds

Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

Human Heredity

Prioritized subset analysis: improving power in genome-wide association studies

Human HeredityOctober 16, 2007
Chun LiRichard M Watanabe
Inflammatory Bowel Diseases

Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information

Inflammatory Bowel DiseasesOctober 19, 2016
Valerie CollijRinse K Weersma
Paper Details
References
  • References
  • Citations1
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
/papers/computational-drug-repurposing-for-inflammatory/30728920